Medical News

RSS

New tool for predicting disease course in children with Crohn's disease

A new study published in the journal Inflammatory Bowel Diseases develops a computer based visual tool that can be used in “real time” to show pediatric Crohn’s disease (CD) patients’ predicted disease course and how this might be influenced by different treatment options.

6 Dec 2010

New report reveals how African countries are performing in budgeting for their children

A new report launched today by The African Child Policy Forum (ACPF) measures African government’s investment in children and confirms that a country’s commitment to child rights and wellbeing is not dependent on their economic status, but rather on political will and spending priorities.

6 Dec 2010

Achillion Pharmaceuticals to present clinical study data of ACH-1625 at APASL 2011

Achillion Pharmaceuticals, Inc. today announced that data from the Company's ongoing clinical studies of ACH-1625 has been accepted for presentation at the 21st Annual Conference of the Asian Pacific Association for the Study of the Liver to be held February 17-21, 2011 in Bangkok, Thailand.

6 Dec 2010

PAREXEL International opens two new Clinical Logistics Services facilities

PAREXEL International Corporation, a leading global biopharmaceutical services provider, today announced that it has opened two new Clinical Logistics Services facilities in emerging regions for biopharmaceutical development. PAREXEL's new depot in Singapore and ancillary warehouse in Russia will support its clients in more effectively managing their global clinical trial supply requirements.

From Parexel 6 Dec 2010

Preclinical data of ZIO-101 in various lymphoma models presented at ASH 2010

ZIOPHARM Oncology, Inc. announced today that new preclinical data on the novel mechanism of its organic arsenic darinaparsin (ZIO-101) in various lymphoma models were presented at the 52nd Annual Meeting and Exposition of the American Society of Hematology in Orlando Florida.

6 Dec 2010

Exiqon announces launch of 6th generation of miRCURY LNA microRNA Arrays

Exiqon A/S, a leading supplier of high-value gene expression analysis products, today announced the launch of the 6th generation of miRCURY LNA microRNA Arrays for expression profiling of microRNA from human, mouse and rat.

6 Dec 2010

Fraunhofer USA CMB receives FDA approval to initiate Phase I clinical trial of H5N1 influenza vaccine

Fraunhofer USA Center for Molecular Biotechnology announced today it has received approval from the Food and Drug Administration to proceed with the first human clinical trial of plant-produced H5N1 influenza vaccine.

6 Dec 2010

Asuragen, Novartis to develop ARQ BCR-ABL1 RNA IS Calibrators, laboratory software reporting tools

Asuragen, Inc. announced today that it has entered into an exclusive agreement with Novartis to develop worldwide Armored RNA Quant BCR-ABL1 RNA International Scale Calibrators and laboratory software reporting tools, intended to aid laboratories with standardization of BCR-ABL1 RT-qPCR testing to the International Scale. As part of this agreement, Asuragen will develop and, if successful, distribute the ARQ BCR-ABL1 IS RNA Calibrators and software reporting tools to laboratories globally directly or through its distributors.

6 Dec 2010

Tapping young people's usage of online social networks could help control rise in HIV: Study

Tapping into young people's use of online social networks presents health agencies with a powerful opportunity to help control the rise in HIV and other sexually transmitted infections in homeless youth in Los Angeles. According to new research by Sean Young from UCLA and Eric Rice from USC in the US, online social networking - and the topics discussed on these networks - have the potential to affect sexual risk behaviors.

6 Dec 2010

New, HIV-like retroviruses linked to CFS, prostate cancer detected in healthy blood donors

In an unprecedented move, chronic fatigue syndrome patients published a half-page ad in The Washington Post today. The ad brings attention to new, HIV-like retroviruses, including XMRV, which have been linked to CFS and aggressive prostate cancer, and have been detected in healthy blood donors.

6 Dec 2010

Nation's top insurance lawyer suggests people to take steps before changing health insurance policy

By now, Americans everywhere are receiving premium increases and new policy choices when it comes to healthcare. Subscribers' rates are increasing and companies are making decisions about what they plan to do with the rising costs heading their way, says Frank N. Darras, the nation's top insurance lawyer.

6 Dec 2010

Alexithymia associated with insecure attachment styles, emotional trauma: Research

Alexithymia is inversely related to mentalization and is associated with insecure attachment styles and emotional trauma, which influence the capacity to regulate affects induced by stressful events. Alexithymia and intrapsychic conflicts may both contribute to the pathogenesis of panic attacks.

6 Dec 2010

Performance of Myconostica's MycAssay Aspergillus in CF reported at British Thoracic Society meeting

At the prestigious annual British Thoracic Society meeting in London on December 1st, Dr Caroline Baxter reported the highly sensitive performance of Myconostica's real-time PCR assay MycAssayTM Aspergillus in cystic fibrosis sputum which is 260% more sensitive than the currently used culture.

6 Dec 2010

HHS, U.S. Treasury Department recognize Integrated Medical Systems' technolgy

The medical technology developed by Integrated Medical Systems, Inc., has been recognized by the U.S. Department of Health and Human Services and the U.S. Treasury Department as a "qualified therapeutic discovery." The designation earns the company a grant to off-set its development efforts. The Qualifying Therapeutic Discovery Project designation and grant is provided for under the Patient Protection and Affordable Care Act of 2010.

6 Dec 2010

$Allos Therapeutics reports new analysis of PROPEL trial data of FOLOTYN in patients with refractory PTCL$

Allos Therapeutics reports new analysis of PROPEL trial data of FOLOTYN in patients with refractory PTCL

Allos Therapeutics, Inc. today reported new analysis of data from the Company's pivotal PROPEL trial of FOLOTYN (pralatrexate injection) in patients with relapsed or refractory peripheral T-cell lymphoma at the 52nd American Society of Hematology Annual Meeting in Orlando, Florida.

6 Dec 2010

NovaBay Pharmaceuticals, Galderma expand their multi-year collaboration agreement

NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, and Galderma, a global leading pharmaceutical company dedicated exclusively to the field of dermatology, announce the expansion of their multi-year collaboration agreement. Based on positive data assessing the activity of NovaBay's Aganocide compounds against impetigo, Galderma has agreed to exercise its option for this indication.

6 Dec 2010

MenAfriVac to help health workers eliminate meningococcal A epidemics

The West African nation of Burkina Faso today became the first country to begin a nationwide campaign to introduce a new meningitis vaccine that promises to rid the entire region of the primary cause of epidemic meningitis. The first vaccine designed specifically for Africa, MenAfriVac is expected to help health workers eliminate meningococcal A epidemics in the 25 countries of the meningitis belt, stretching from Senegal in the west to Ethiopia in the east.

6 Dec 2010

GP Medical, Beijing Yuande named in Deloitte Technology Fast 500 Asia Pacific 2010 program

China Medical Technologies, Inc., a leading China-based advanced in-vitro diagnostic company, today announced that its wholly-owned subsidiaries, Beijing GP Medical Technologies Co., Ltd. and Beijing Yuande Bio-Medical Engineering Co., Ltd., have been ranked 12th and 415th, respectively, in the Deloitte Technology Fast 500 Asia Pacific 2010 program.

6 Dec 2010

Annual BioPartnering China conference launched at Renaissance Shanghai Pudong Hotel

The 3rd Annual BioPartnering China conference, co-produced by TVG and the Zhangjiang Biotech Pharmaceutical Base, launched today at the Renaissance Shanghai Pudong Hotel. The conference attracts a global representation of industry leaders from China, Europe and the USA.

6 Dec 2010

ConvaTec Healthcare offers $1,870,000,000 in Senior Secured Notes, Senior Notes

ConvaTec Healthcare, a world-leading developer, manufacturer and marketer of innovative medical technologies for community and hospital care, today announced that in connection with a refinancing of its debt under its existing senior secured and mezzanine facilities and in combination with new senior secured credit facilities, it is offering $1,870,000,000 (equivalent) in Senior Secured Notes and Senior Notes.

6 Dec 2010

Medical News

New tool for predicting disease course in children with Crohn's disease

New report reveals how African countries are performing in budgeting for their children

Achillion Pharmaceuticals to present clinical study data of ACH-1625 at APASL 2011

PAREXEL International opens two new Clinical Logistics Services facilities

Preclinical data of ZIO-101 in various lymphoma models presented at ASH 2010

Exiqon announces launch of 6th generation of miRCURY LNA microRNA Arrays

Fraunhofer USA CMB receives FDA approval to initiate Phase I clinical trial of H5N1 influenza vaccine

Asuragen, Novartis to develop ARQ BCR-ABL1 RNA IS Calibrators, laboratory software reporting tools

Tapping young people's usage of online social networks could help control rise in HIV: Study

New, HIV-like retroviruses linked to CFS, prostate cancer detected in healthy blood donors

Nation's top insurance lawyer suggests people to take steps before changing health insurance policy

Alexithymia associated with insecure attachment styles, emotional trauma: Research

Performance of Myconostica's MycAssay Aspergillus in CF reported at British Thoracic Society meeting

HHS, U.S. Treasury Department recognize Integrated Medical Systems' technolgy

Allos Therapeutics reports new analysis of PROPEL trial data of FOLOTYN in patients with refractory PTCL

NovaBay Pharmaceuticals, Galderma expand their multi-year collaboration agreement

MenAfriVac to help health workers eliminate meningococcal A epidemics

GP Medical, Beijing Yuande named in Deloitte Technology Fast 500 Asia Pacific 2010 program

Annual BioPartnering China conference launched at Renaissance Shanghai Pudong Hotel

ConvaTec Healthcare offers $1,870,000,000 in Senior Secured Notes, Senior Notes

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News